Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Catheter Precision (VTAK) Shares Outstanding (Weighted Average) (2017 - 2025)

Catheter Precision has reported Shares Outstanding (Weighted Average) over the past 9 years, most recently at $1.1 million for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 529.09% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, up 529.09% year-over-year, with the annual reading at $1.1 million for FY2025, 529.09% up from the prior year.
  • Shares Outstanding (Weighted Average) was $1.1 million for Q4 2025 at Catheter Precision, roughly flat from $1.1 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $1.1 billion in Q3 2022 and troughed at $128.0 in Q3 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $1.1 million (2022), against an average of $103.5 million.
  • Year-over-year, Shares Outstanding (Weighted Average) crashed 99.99% in 2021 and then soared 853311618.75% in 2022.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $101000.0 in 2021, then skyrocketed by 923.59% to $1.0 million in 2022, then grew by 6.81% to $1.1 million in 2023, then plummeted by 84.44% to $171774.0 in 2024, then surged by 529.09% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Shares Outstanding (Weighted Average) are $1.1 million (Q4 2025), $1.1 million (Q3 2025), and $20.5 million (Q2 2025).